Psyence Biomedical Ltd. (PBM)
NASDAQ: PBM · Real-Time Price · USD
2.360
-2.670 (-53.08%)
At close: Aug 1, 2025, 4:00 PM
3.970
+1.610 (68.22%)
After-hours: Aug 1, 2025, 7:59 PM EDT
CTI BioPharma Market Cap
Psyence Biomedical has a market cap or net worth of $1.38 million as of August 1, 2025. Its market cap has decreased by -73.57% in one year.
Market Cap
1.38M
Enterprise Value
-4.76M
1-Year Change
-73.57%
Ranking
Category
Stock Price
$2.36
Market Cap Chart
Since December 10, 2021, Psyence Biomedical's market cap has decreased from $323.48M to $1.38M, a decrease of -99.57%. That is a compound annual growth rate of -77.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 1.38M | -85.26% |
| Dec 31, 2024 | 9.34M | -88.50% |
| Dec 29, 2023 | 81.20M | -75.83% |
| Dec 30, 2022 | 335.90M | 3.73% |
| Dec 31, 2021 | 323.81M | 0.10% |
| Dec 10, 2021 | 323.48M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 684.93B |
| Johnson & Johnson | 404.87B |
| AbbVie | 337.77B |
| Novo Nordisk | 238.11B |
| UnitedHealth Group | 236.83B |
| AstraZeneca | 230.79B |
| Novartis AG | 227.32B |
| Abbott Laboratories | 222.72B |